Supportive Release Center Study
Not Applicable
Active, not recruiting
- Conditions
- Mental HealthMental Health ServicesSubstance UseContinuity of Patient CareRecidivism
- Interventions
- Behavioral: TASC Service Linkages - Discharge Area OnlyBehavioral: SRC Overnight StayBehavioral: TASC Services Linkages - SRC OnsiteBehavioral: APN Appointment
- First Posted Date
- 2018-08-06
- Last Posted Date
- 2023-05-10
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 15195
- Registration Number
- NCT03616990
- Locations
- 🇺🇸
Cook County Department of Corrections & SRC, Chicago, Illinois, United States
Pembrolizumab and EDP1503 in Advanced Melanoma
Phase 2
Active, not recruiting
- Conditions
- Melanoma (Skin)Melanoma
- Interventions
- Drug: PembrolizumabBiological: EDP1503
- First Posted Date
- 2018-07-23
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 8
- Registration Number
- NCT03595683
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
An Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury
Not Applicable
Recruiting
- Conditions
- Acute Kidney Injury
- Interventions
- Other: Standard of Care (SOC)Other: Early Nephrology Consult (ENC)
- First Posted Date
- 2018-07-18
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 180
- Registration Number
- NCT03590028
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy
Not Applicable
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Procedure: Diagnostic MRIProcedure: Diagnostic Prostate BiopsyDevice: Risk Map DSS tool
- First Posted Date
- 2018-07-13
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 100
- Registration Number
- NCT03585660
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
Phase 1
Terminated
- Conditions
- Endometrial CancerProstate Cancer
- Interventions
- First Posted Date
- 2018-06-28
- Last Posted Date
- 2021-03-09
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 12
- Registration Number
- NCT03572478
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
Phase 1
Recruiting
- Conditions
- ALL, ChildhoodALLAcute Lymphoblastic Leukemia
- Interventions
- Drug: RuxolitinibDrug: CyclophosphamideDrug: CytarabineDrug: MercaptopurineDrug: VincristineDrug: PegaspargaseDrug: RituximabDrug: Methotrexate (Intrathecal Administration)Drug: Methotrexate (Intravenous Administration)Drug: DexamethasoneDrug: DoxorubicinDrug: ThioguanineDrug: Methotrexate Oral Product
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 15
- Registration Number
- NCT03571321
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
An Emotion-Focused Intervention for Glycemic Control in T2D
Not Applicable
Completed
- Conditions
- Type2 Diabetes
- Interventions
- Behavioral: Emotion-Focused CBT
- First Posted Date
- 2018-06-12
- Last Posted Date
- 2020-04-22
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 20
- Registration Number
- NCT03553680
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors
- First Posted Date
- 2018-05-21
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 50
- Registration Number
- NCT03530800
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
Phase 2
Active, not recruiting
- Conditions
- Multiple MyelomaMyeloma
- Interventions
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 75
- Registration Number
- NCT03500445
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Medical Care, Education, Social Support, And Goal-setting to Empower Self-management for Diabetes
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Other: Diabetes MESSAGES Program (second trial)Other: Diabetes MESSAGES Program
- First Posted Date
- 2018-04-04
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 265
- Registration Number
- NCT03487692
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath